(SPGP) Invesco SP500 GARP - Ratings and Ratios
Large-Cap, Equities, Growth, Quality
Dividends
| Dividend Yield | 1.23% |
| Yield on Cost 5y | 2.15% |
| Yield CAGR 5y | 16.28% |
| Payout Consistency | 94.3% |
| Payout Ratio | - |
| Risk via 10d forecast | |
|---|---|
| Volatility | 16.2% |
| Value at Risk 5%th | 27.3% |
| Relative Tail Risk | 2.12% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.02 |
| Alpha | -13.32 |
| CAGR/Max DD | 0.44 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.263 |
| Beta | 1.012 |
| Beta Downside | 1.035 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.87% |
| Mean DD | 4.14% |
| Median DD | 3.26% |
Description: SPGP Invesco SP500 GARP November 08, 2025
The Invesco S&P 500 GARP ETF (SPGP) aims to allocate at least 90% of its assets to the securities that compose its benchmark index, which selects roughly 75 S&P 500 constituents that score highly on both growth and quality/value metrics. The index methodology follows strict, pre-defined guidelines to ensure consistent exposure to high-quality growth stocks while maintaining a value overlay.
As of the latest reporting period, SPGP’s top sector weights are Technology (~30%), Health Care (~20%) and Consumer Discretionary (~15%), reflecting the current dominance of innovative, earnings-driven firms. The fund’s expense ratio stands at 0.35%, and its 12-month trailing total return has averaged about 11%, outperforming the broader S&P 500’s 9% return in the same window. A key driver for future performance will be the U.S. monetary policy trajectory, since lower rates tend to boost growth-oriented equities, while the ongoing corporate earnings rebound supports the quality tilt.
For a deeper, data-rich analysis of SPGP’s valuation and risk profile, you might explore the detailed metrics available on ValueRay.
What is the price of SPGP shares?
Over the past week, the price has changed by +3.92%, over one month by -2.35%, over three months by -0.16% and over the past year by +1.64%.
Is SPGP a buy, sell or hold?
What are the forecasts/targets for the SPGP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 121.8 | 8.5% |
SPGP Fundamental Data Overview November 24, 2025
Beta = 1.06
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 2.37b USD (2.37b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 2.37b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 2.37b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.74% (E(2.37b)/V(2.37b) * Re(9.74%) + (debt-free company))
Discount Rate = 9.74% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for SPGP ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle